REGENXBIO, Inc. (RGNX)
8.57
-0.51
(-5.62%)
USD |
NASDAQ |
Mar 13, 16:00
8.56
-0.01
(-0.12%)
After-Hours: 20:00
REGENXBIO Shareholders Equity (Quarterly) : 102.73M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.141B |
| AbbVie, Inc. | -3.27B |
| Replimune Group, Inc. | 210.54M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Altimmune, Inc. | 224.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 453.03M |
| Total Liabilities (Quarterly) | 350.30M |
| Debt to Equity Ratio | 2.536 |
| Current Ratio | 2.382 |
| Net Debt Paydown Yield | -3.13% |